Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Hamaz Pharmaceuticals (Pvt) Ltd.

Private pharmaceutical manufacturer · Multan · Pakistan

Multan-based pharmaceutical manufacturer appearing in DRAP product records as a contract manufacturing site.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Hamaz Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
13-KM Bosan Road, Lutfabad, Multan, Pakistan
Corporate source details checked
16 Aug 2026
Corporate profile completeness
63%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000427 Hamaz Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000427 151 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx153public portfolio records represented
REG110unique registrations represented
IDX150indexed MedInfoBase presentations
SRC2additional source-observed presentations
R+1registry-only registrations
VER0registry-verified exact registrations
PKR134current validated price records
G55generic molecules in indexed catalogue
DF10dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage88%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixHamaz Pharmaceuticals (Pvt) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/hamaz-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026Anti-infectives101 · 67%Pain & musculoskeletal15 · 10%Gastrointestinal & hepatology8 · 5%Oncology & immunology6 · 4%Cardiovascular5 · 3%Respiratory & allergy4 · 3%Vitamins, minerals & nutrition3 · 2%Other therapeutic areas8 · 5%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioHamaz Pharmaceuticals (Pvt) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/hamaz-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026150presentationsTablet64 · 43%Injection26 · 17%Suspension17 · 11%Capsule13 · 9%Cream8 · 5%Infusion8 · 5%Other forms14 · 9%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionHamaz Pharmaceuticals (Pvt) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/hamaz-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026139comparable productsBelow peer median53 · 38%Near peer median54 · 39%Above peer median32 · 23%Company median price position0.0%Lowest-price equivalents13Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsHamaz Pharmaceuticals (Pvt) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/hamaz-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026Mediate Pharmaceutical Pvt Ltd38 shared69% overlapNeutro Pharma (Pvt.) Ltd.,37 shared67% overlapNabiqasim Industries (Pvt) Ltd.,33 shared60% overlapPharmasol (Pvt) Ltd.32 shared58% overlapBio-Labs(Pvt) Ltd32 shared58% overlapBosch Pharmaceuticals (Pvt) Ltd.31 shared56% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives101 products · 67%
Pain & musculoskeletal15 products · 10%
Gastrointestinal & hepatology8 products · 5%
Oncology & immunology6 products · 4%
Cardiovascular5 products · 3%
Respiratory & allergy4 products · 3%
Vitamins, minerals & nutrition3 products · 2%
Hematology & thrombosis3 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins24 products · 16%
Penicillin antibacterials18 products · 12%
Analgesics / NSAIDs15 products · 10%
Antimalarials13 products · 9%
Fluoroquinolone antibacterials13 products · 9%
Antifungals9 products · 6%
Nitroimidazole anti-infectives7 products · 5%
Antiemetics6 products · 4%
Formulation footprint

Dosage forms

Tablet64 products
Injection26 products
Suspension17 products
Capsule13 products
Cream8 products
Infusion8 products
Syrup8 products
Drops4 products
Ointment1 products
Sachet1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 SkymoxAmoxicillin 13presentations 1000 mg, 125 mg/5 mL, 250 mg, 250 mg/5 mL · Tablet, Drops, Syrup #2 EstadolParacetamol 8presentations 1 g, 120 mg/5 mL, 250 mg/5 mL, 500 mg · Infusion, Suspension, Tablet #3 TeraxoneCeftriaxone 8presentations 1 g, 250 mg, 500 mg · Injection #4 NixinCiprofloxacin 7presentations 125 mg/5 mL, 200 mg, 250 mg, 250 mg/5 mL · Suspension, Infusion, Tablet #5 SpizoleMetronidazole 7presentations 200 mg, 200 mg/5 mL, 400 mg, 500 mg · Tablet, Suspension, Infusion #6 BactazimeCeftazidime 6presentations 1 g, 250 mg, 500 mg · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median5338% of comparable products
Near market median54within ±5% of median
Above market median3223% of comparable products
Lowest-price equivalents13ties included
Company median price position 0.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
VYI 150 mgFluconazole · Capsule · 1's PKR 118.82/capsule-55.0% vs market median Skymox 1000 mgAmoxicillin · Tablet · 10x10s PKR 13.46/tablet-50.5% vs market median Skymox 1000 mgAmoxicillin · Tablet · 12's PKR 14.96/tablet-45.0% vs market median Velberta 0.1%Betamethasone · Cream · 15gm PKR 2.64/g-42.6% vs market median Hamzolid 200 mgLinezolid · Injection · 100ml PKR 4.29/mL-39.1% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 38shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 37shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 33shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 32shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 32shared generics Bosch Pharmaceuticals (Pvt) Ltd.258 products · 74 generics 31shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers108Distinct registrations among indexed, published, presentation-validated products only
Verified price observations150
Products with a verified price150
Products with multiple price observations0
Source records with multiple versions150
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

110 unique registration(s) · 150 indexed presentation(s) · 2 additional source-observed presentation(s) · 1 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Phosoquine Chloroquine 250 mg Tablet 1000s 005530 PKR 3,363.15 PKR 3.36/tablet 118% above median
Phosoquine plus Hydroxychloroquine 200 mg Tablet 50's 103365 PKR 722.57 PKR 14.45/tablet Near median
Phosoquine plus Hydroxychloroquine 200 mg Tablet 30's 103365 PKR 433.54 PKR 14.45/tablet Near median
Plgrol-3h Clopidogrel 75 mg Tablet 1x10s 040709 PKR 279.26 PKR 27.93/tablet Near median
Skymox Amoxicillin 250 mg Capsule 10x50's 000890 PKR 5,419.98 PKR 10.84/capsule Near median
Skymox Amoxicillin 250 mg Capsule 10x10's 000890 PKR 1,129.16 PKR 11.29/capsule Near median
Skymox Amoxicillin 250 mg Capsule 10x100's 000890 PKR 10,839.96 PKR 10.84/capsule Near median
Skymox Amoxicillin 500 mg Capsule 500s 002673 PKR 9,578.08 PKR 19.16/capsule Near median
Skymox Amoxicillin 500 mg Capsule 10x10s 002673 PKR 1,995.43 PKR 19.95/capsule Near median
Skymox Amoxicillin 125 mg/5 mL Syrup 90ml 008184 PKR 136.66 PKR 1.52/mL Near median
Skymox Amoxicillin 125 mg/5 mL Syrup 60ml 008184 PKR 91.49 PKR 1.52/mL Near median
Skymox Amoxicillin 125 mg/5 mL Oral drops 20ml 021323 PKR 66.17 PKR 3.31/mL Near median
Skymox Amoxicillin 125 mg/5 mL Oral drops 10ml 021323 PKR 34.22 PKR 3.42/mL Near median
Skymox Amoxicillin 250 mg/5 mL Syrup 90ml 021324 PKR 202.67 PKR 2.25/mL Near median
Skymox Amoxicillin 250 mg/5 mL Syrup 60ml 021324 PKR 134.34 PKR 2.24/mL Near median
Skymox Amoxicillin 1000 mg Tablet 12's 059938 PKR 179.52 PKR 14.96/tablet 45% below median
Skymox Amoxicillin 1000 mg Tablet 10x10s 059938 PKR 1,346.43 PKR 13.46/tablet 51% below median
Spizole Metronidazole 200 mg/5 mL Suspension 60ml 046955 PKR 67.76 PKR 1.13/mL 25% above median
Spizole Metronidazole 400 mg Tablet 2x10's 046965 PKR 72.45 PKR 3.62/tablet 22% above median
Spizole Metronidazole 400 mg Tablet 10x10's 046965 PKR 362.25 PKR 3.62/tablet 22% above median
Spizole Metronidazole 400 mg Tablet 250's 046965 PKR 574.03 PKR 2.30/tablet 24% below median
Spizole Metronidazole 200 mg Tablet 500's 049128 PKR 803.64 PKR 1.61/tablet 25% below median
Spizole Metronidazole 200 mg Tablet 20x10's 049128 PKR 499.16 PKR 2.50/tablet 17% above median
Spizole Metronidazole 500 mg IV infusion 100ml 102579 PKR 189.93 PKR 1.90/mL Near median
Suncef Cefixime 400 mg Capsule 5x10's 059937 PKR 5,350.19 PKR 107.00/capsule 5% below median
Suncef Cefixime 400 mg Capsule 5's 059937 PKR 592.04 PKR 118.41/capsule Near median
Suncef Cefixime 100 mg/5 mL Suspension 30ml 059950 PKR 330.39 PKR 11.01/mL Near median
Suncef Forte Cefixime 200 mg/5 mL Suspension 30ml 059948 PKR 404.32 PKR 13.48/mL Near median
Telmintic Mebendazole 100 mg Tablet 6x10's 046959 PKR 345.08 PKR 5.75/tablet 16% below median
Telmintic Mebendazole 100 mg/5 mL Suspension 30ml 054272 PKR 79.78 PKR 2.66/mL 9% below median
Teraxone Ceftriaxone 1 g Injection 25's 052901 PKR 14,465.85 PKR 578.63/vial/unit Near median
Teraxone Ceftriaxone 1 g Injection 1's 052901 PKR 640.30 PKR 640.30/vial/unit 7% above median
Teraxone Ceftriaxone 500 mg Injection 1's 052905 PKR 339.10 PKR 339.10/vial/unit Near median
Teraxone Ceftriaxone 250 mg Injection 1's 052913 PKR 201.47 PKR 201.47/vial/unit Near median
Teraxone Ceftriaxone 250 mg Injection 25's 080095 PKR 4,551.63 PKR 182.07/vial/unit 5% below median
Teraxone Ceftriaxone 250 mg Injection 1's 080095 PKR 201.47 PKR 201.47/vial/unit Near median
Teraxone Ceftriaxone 500 mg Injection 25's 080096 PKR 7,660.96 PKR 306.44/vial/unit 7% below median
Teraxone Ceftriaxone 500 mg Injection 1's 080096 PKR 339.10 PKR 339.10/vial/unit Near median
Torlip - 3h Atorvastatin 10 mg Tablet 10's 040710 PKR 498.67 PKR 49.87/tablet 81% above median
Torlip - 3h Atorvastatin 20 mg Tablet 10's 040711 PKR 730.06 PKR 73.01/tablet 56% above median
Tringa B Betamethasone + Clotrimazole 1% + 0.05% Cream 10gm 114141 PKR 52.81 PKR 5.28/g No comparator
Tringa V Clotrimazole 2% Cream 35gm(with applicator) 114140 PKR 180.67 — No comparator
Ultavit-C Paracetamol 500 mg Tablet 40's 000893 PKR 107.82 PKR 2.70/tablet 26% below median
Velberta Betamethasone 0.1% Cream 15gm 115395 PKR 39.61 PKR 2.64/g 43% below median
Velberta Betamethasone 1 mg/g (0.1%) Cream 5gm 115395 PKR 14.52 PKR 2.90/g 33% below median
Vit-ham.C Ascorbic acid 500 mg Chewable tablet 40's 103367 PKR 48.17 PKR 1.20/tablet 9% below median
VYI Fluconazole 100 mg/50 mL IV infusion 50ml 102580 PKR 504.12 PKR 10.08/mL 40% above median
VYI Fluconazole 150 mg Capsule 1's 115400 PKR 118.82 PKR 118.82/capsule 55% below median
Xero-sed Cetirizine 10 mg Tablet 1x10s 054280 PKR 83.78 PKR 8.38/tablet Near median
Xero-sed Cetirizine 10 mg Tablet 10x10s 054280 PKR 757.13 PKR 7.57/tablet 7% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Hamaz Pharmaceuticals (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/hamaz-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.